This article was originally published on Nov. 8 on giving.jhu.edu
Between 2001 and the beginning of 2018, more than 1,500 U.S. military service members lost limbs in the line of duty. Although technology has improved the prosthetic devices these people can use, a stubborn obstacle remains: the fragility of human skin.
"Skin was never meant to hold this kind of pressure," says Lee Childers, the senior scientist for the Extremity Trauma and Amputation Center of Excellence at Brooke Army Medical Center in San Antonio, Texas.
"Think about it like a blister on your foot. It's painful, but you can still get by," he continues. "In an amputation, it's a blister on your residual limb. You can't use your prosthesis until the blister is completely healed. If it's your leg [that is affected], you can't walk for two or three weeks. Think about how that would impact your life."
What if there were a way to make the skin at an amputation site tougher, like the palm of your hand or the sole of your foot? Luis Garza, an associate professor of dermatology at Johns Hopkins and leader of the Veteran Amputee Skin Regeneration Program, is developing a cell therapy that could enable prosthetics wearers to use their devices longer.
"This is an example of personalized medicine," Garza says. "We're taking each person's own cells, growing them up, and inserting them back in."
Garza's postdoctoral research focused on skin stem cells. In 2009, he and his department chair, Sewon Kang, began having conversations about how that work could help the increasing numbers of veterans coming back from war with amputations. Garza and his team received grants from the U.S. Department of Defense, National Institutes of Health, and Maryland Stem Cell Fund that have moved the program forward in the past decade.
Garza's team spent the summer of 2019 testing "normal" subjectsthose without amputationsto perfect the procedure, including the dose, content, method, and frequency of the injections. During one appointment, members of Garza's team took biopsies of skin from a subject's scalp and sole. The cells went to a lab where they were grown under an FDA-approved protocol and passed through quality control tests.
In a second appointment, subjects completed a questionnaire and underwent baseline measurements of their skin's thickness and strength. Garza's team then injected a site on the subjects' skin with the stem cells grown from their cells in the lab.
Image caption: Luis Garza, associate professor of dermatology at Johns Hopkins, leads the Veteran Amputee Skin Regeneration Program.
"We're hoping that these stem cell populations will engraft in the new skin," Garza says.
The subjects returned to Hopkins several months later to go through the questionnaire and measurements once more, and Garza's team documented changes.
Confident in the results they gleaned from the normal subjects, Garza's team enrolled its first subject with an amputation in August. Moving from the normal population to the amputation-affected population quickly unearthed some aspects of the therapy Garza didn't anticipate.
"When we talked with him, he said 'I don't want to mess with my one remaining footdo you have to take skin from there?' And we said, 'Actually, no, we could do your palm,'" Garza says.
His team then tested the biopsy and growth of palm cells from subjects in the normal population. "We're moving away from having our product informed purely by biology to letting our therapy development be shaped by the user."
Although federal grants have supported much of the program's progress, private philanthropy has played a role, too. Corporations like Northrop Grumman, foundations like the Alliance for Veteran Support, and grateful patients with and without ties to the armed forces have contributed nearly $300,000. Those gifts have enabled the program to persevere through gaps between federal grants.
A man sits at a desk, speaking with another man who sits beside him. A large microscope sits on the desk, and a brightly colored image of a skin biopsy appears on a computer screen.
Private funds will be increasingly important as the project enters its next phase: extension to military medical centers around the country. Garza's team must prove that the safeguards to protect cells on their round-trip voyage from a test site to Hopkins are effective. They also must secure approval by local institutional review boards for clinical studies.
"Soldiers are used to getting orders, but you can't order someone to be part of a [medical] study," Garza says. "There are hard medical ethics questions around how to make this open to them but ensure they don't feel obligated. We've been working on that for a year, and we probably have another six months or so to go."
Childers stands ready for whenever the program's extension is a go. He will lead the study at Brooke Army Medical Center and feels motivated by the prospect of helping many of the veterans he works with every day.
"We do everything we can to serve those who serve us. This can enable people to return to duty and be redeployed if they choose," he says. "This is game-changing technology that will have an impact for our service members, but also others who live with amputation."
That population includes the hundreds of thousands of Americans who've undergone amputations for complications of diabetes, who must use a wheelchair, or who wear ankle or foot orthoses for help with walking, among others.
"Having the ability to transform skin anywhere you want to target on the body will have gigantic implications across the entire spectrum of our society in many ways," Childers says.
There's a lot of work to be done before such benefits reach the public, Garza cautions. With continued support from donors and the military community, though, he's optimistic about the program's future.
"The challenges are pretty big, but I think within five years, it could happen," he says. "That's the hope."
Disclaimer: The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of the Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of the Air Force and Department of Defense or the U.S. Government.
Read the rest here:
Serving those who serve us - The Hub at Johns Hopkins
- BrainStorm Cell Therapeutics COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research Summit - Yahoo Finance - January 22nd, 2020
- Neurogenesis could be a therapeutic target in neurodegenerative disease - Drug Target Review - January 22nd, 2020
- Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway - BioSpace - January 22nd, 2020
- Animal Stem Cell Therapy Market Global and Regional Analysis by Top Key Market Players, Key Regions, Product Segments, and Applications 2024 ... - January 22nd, 2020
- At 35.7% CAGR, Animal Stem Cell Therapy Market Size will reach 108.3 million USD by 2025 - MENAFN.COM - January 22nd, 2020
- Global Cholangiocarcinoma Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company |... - January 22nd, 2020
- 1000 Entrepreneurs: Ken Aldrich on 30 Years of Venture Capital and 50 Successful Businesses - GuruFocus.com - January 22nd, 2020
- Preparing the youth - The News International - January 22nd, 2020
- Canine Stem Cell Therapy Market Extensive Growth Opportunities to Be Witnessed by 2019-2026 - Fusion Science Academy - January 22nd, 2020
- Cell Separation Technologies Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 2026 - Dagoretti News - January 22nd, 2020
- Europe's guardian of stem cells and hopes, real and unrealistic - FRANCE 24 - January 21st, 2020
- Psychiatric body condemns use of stem cell therapies to treat psychiatric disorders - Moneycontrol.com - January 21st, 2020
- Astellas partners with Adaptimmune to develop off-the-shelf CAR-T and T-cell therapies - Healio - January 21st, 2020
- Could Scientists 'Hack' the Zika Virus to Kill Brain Cancer? - Livescience.com - January 20th, 2020
- Product Innovations and Technological Advancements to Boost the Growth of the Stem Cell Therapy Market in the Upcoming Years 2017 2025 Dagoretti... - January 20th, 2020
- Stem Cell Cartilage Regeneration Market Report 2019:2026 Industry Growth Forecasts by Manufacturers, Countries, Type and Application Dagoretti News... - January 20th, 2020
- Market opportunity and growth drivers of Cell Separation Technology Market till 2025 Dagoretti News - Dagoretti News - January 20th, 2020
- Stem Cell Research: Uses, Types & Examples - January 19th, 2020
- Stem Cell Assay Market expected to Witness a Sustainable Growth over 2016 2024 Dagoretti News - Dagoretti News - January 19th, 2020
- 2D Cell Culture Market to Witness Growth Acceleration During 2020 to 2026 Dagoretti News - Dagoretti News - January 19th, 2020
- Stem Cell and Progenitor Cell-based therapeutics Market 2020 Share Growing Rapidly with Recent Trends, Growth, Size, Share, Clinical Review,... - January 18th, 2020
- Animal Stem Cell Therapy Market Poised to Garner Maximum Revenues During 2017 2025 Dagoretti News - Dagoretti News - January 18th, 2020
- Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies - Yahoo... - January 18th, 2020
- Universities aren't making a lot of money from university research - The Hechinger Report - January 18th, 2020
- R&D Activities to Fast-track the Growth of the Biobanks Market Between 2017 2025 Dagoretti News - Dagoretti News - January 18th, 2020
- Rheumatoid Arthritis Stem Cell Therapy Market Latest Innovations, Drivers and Industry Key Events 2018 to 2028 - Fusion Science Academy - January 18th, 2020
- Heart Cell Research Leads to Discovery That May Lead to Unreliable Data - Newswise - January 17th, 2020
- Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2019 Valuable Growth Prospects and Upcoming Trends till 2024 Dagoretti News... - January 17th, 2020
- In Vitro Lung Model Market to 2027 Increasing Adoption Of 3D Model Systems - PharmiWeb.com - January 17th, 2020
- Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl | DDDT - Dove Medical Press - January 15th, 2020
- Global Stem Cell Reconstructive Market 2019 Share, Trend, Segmentation and Forecast to 2025 - Instanews247 - January 15th, 2020
- The Checkout: Powering Plant and Cell-based Innovations - NOSH - January 11th, 2020
- Cultured Meat Startup New Age Meats Secures $2.7M in Seed Round - vegconomist - the vegan business magazine - January 11th, 2020
- Stem Cell Gun Devices Market Projected to Witness Vigorous Expansion by 2019 2027 - Food & Beverage Herald - January 11th, 2020
- Stem Cell Manufacturing Market Size, Top Companies, Business Opportunities and Growth 2020 to 2027 - Pro News Time - January 11th, 2020
- TEDCO funds open again for applications - Maryland Daily Record - January 4th, 2020
- Cell Culture Protein Surface Coating Market Competitive Environment and Higher Growth Rate with Forecast to 2025 - Filmi Baba - January 4th, 2020
- Stem Cell Alopecia Treatment Market Segmentation, Top Companies, Applications, Comprehensive Research Report and Forecast to 2026 - Market Research... - December 30th, 2019
- Animal Stem Cell Therapy Market Research Report 2026 Observational Studies With Top Manufacturers - Market Research Sheets - December 30th, 2019
- Stem Cell Cartilage Regeneration Market Key players, Geographical Regions and Growth Analysis Outlook Up To 2028 - Sound On Sound Fest - December 30th, 2019
- Scientists race to use zero gravity to kill the worst cancers - Big Think - December 30th, 2019
- How technology has changed the world in the last decade - The Upcoming - December 30th, 2019
- Stem Cell Market Analysis, Growth By Top Companies, Trends By Types And Application, Forecast Analysis To 2027 - Market Research Sheets - December 30th, 2019
- Don't throw food in the trash in Vermont, or ask about salary history in New Jersey. Here are 7 state law changes for 2020 - USA TODAY - December 28th, 2019
- From the image of a black hole to 'artificial embryos', 2019 was the year of many firsts in science - Economic Times - December 28th, 2019
- Animal Stem Cell Therapy Market: Challenges and Opportunities Report 2017 2025 Bulletin Line - Bulletin Line - December 28th, 2019
- Protein Associated with Leukemia May Lead to Targeted Therapy for Currently Incurable Acute Lymphoblastic Leukemia - Pharmacy Times - December 25th, 2019
- The Next Generation of Biologic Pacemakers? New Discovery in Stem Cells from Fat Creates Another Alternative Treatment - DocWire News - December 25th, 2019
- Study of the 3D Cell Culture Market in Asia-Pacific, 2019-2027: Projecting a 13.11% CAGR, Driven by Promising Developments Using Regenerative Medicine... - December 24th, 2019
- Stem Cells Market Poised to Expand at a Robust Pace Over 2017 to 2025 - Market Research Sheets - December 24th, 2019
- Illuminating Christmas, 19 years and counting... in honour of the Anthony Nolan Charity - London News Online - December 24th, 2019
- The global in vitro lung model market is expected to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018 - Yahoo Finance - December 24th, 2019
- Global and Southeast Asia Embryonic Stem Cell Market 2013-2023 by Top Key Players, YoY Growth, Trends, Size, Share and Revenue Analysis - Market... - December 24th, 2019
- Researchers Create Functional Mini-Liver by 3D Bioprinting - 3D Printing Progress - December 24th, 2019
- FY 2020 Government Funding Bill Repeals ACA Health-Related Taxes, Extends Expiring Health Provisions, Makes Other Health Policy Updates - Lexology - December 24th, 2019
- Making advanced therapies takes industrializing personalization - STAT - December 23rd, 2019
- Global Allogeneic Stem Cells Market 2020-2024 | Evolving Opportunities with Biosolution Co. Ltd. and Cynata Therapeutics Ltd. | Technavio - Yahoo... - December 23rd, 2019
- Stem Cell Market SWOT Analysis 2019 | Industry Leading Players by Size, Share, Industry Revenue, and Regional Forecast to 2024 - Ankeny Observer - December 23rd, 2019
- BeiGene Announces Acceptance of a Supplemental New Drug Application in China for REVLIMID in Relapsed or Refractory Indolent Lymphoma - BioSpace - December 23rd, 2019
- Stem Cell Research & Therapy | Home page - December 18th, 2019
- Global Allogeneic Stem Cells Market 2020-2024 | Evolving Opportunities with Biosolution Co. Ltd. and Cynata Therapeutics Ltd. | Technavio - Business... - December 18th, 2019
- 3D Cell Culture Market: Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation - Global Forecast to 2024 - ResearchAndMarkets.com -... - December 18th, 2019
- Functional "Mini-liver" Created By 3D Bioprinting - Technology Networks - December 18th, 2019
- Scientists hope MND cure is a step closer after stem cell breakthrough discovery - The National - December 18th, 2019
- Stem Cell Banking Market: Adopts Innovation to Stay Competitive Forecast - Market Research Sheets - December 18th, 2019
- Stem Cell Discovery Could Transform Treatment of Tendon Injuries - Gilmore Health News - December 18th, 2019
- Attractive Market Opportunities in the Cord Blood Stem Cell Market By 2029 - Sound On Sound Fest - December 17th, 2019
- Attractive Market Opportunities in the Stem Cell Cartilage Regeneration Market By 2029 - Sound On Sound Fest - December 17th, 2019
- Global Stem Cell Media Market |2018-2023| Qualitative & Quantitative Analysis, Key Vendors Analysis, Reliability, Growth Innovation in Technology... - December 17th, 2019
- Global Stem Cell Therapy Market to Become a Worth US$ 4759.27 Million By 2024 - E-Industry News - December 17th, 2019
- Stem Cell Market to 2025 Analysis by Top Vendors - Space Market Research - December 17th, 2019
- Harvard geneticist George Church's goal: to protect humans from viruses, genetic diseases, and aging - 60 Minutes - CBS News - December 8th, 2019
- Start-up to research on degenerative eye disease - Deccan Herald - December 8th, 2019
- R&D Activities to Fast-track the Growth of the Stem Cell Assay Market Between 2018 2028 - Kentucky Reports - December 8th, 2019
- The Making of a Root - Duke Today - December 5th, 2019
- Engelhardt named 2019 Fellow of the National Academy of Inventors - Iowa Now - December 5th, 2019
- In the Spotlight: 'When you're in a minority group, you're never just a grad student' - Scope - December 5th, 2019
- Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc. - GlobeNewswire - December 5th, 2019
- Dosage analysis of the 7q11.23 Williams region identifies BAZ1B as a major human gene patterning the modern human face and underlying... - December 5th, 2019
- Stem Cell Banking Market expected to Witness a Sustainable Growth over 2028 - VaporBlash - December 5th, 2019